在瘤治疗中应用基于细胞衍生的囊泡的仿生药物递送系统
Yan Mei1, Maochang Liu1, Meng Mei1
1Department of Pharmacy, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in pharmacology
|July 28, 2025
概括
细胞衍生的囊泡是瘤治疗的有前途的天然药物载体,提供增强的生物相容性和向的输送. 本综述探讨了它们在药物输送系统中的应用,以改善癌症治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 细胞衍生的囊泡通过运输蛋白质,细胞因子,mRNA和DNA等生物分子来促进细胞间的通信.
- 这些囊泡因其在瘤生长抑制,转移,诊断和早期查方面的作用而越来越受认可.
- 它们的固有特性比传统的药物输送载体提供了潜在的优势.
研究的目的:
- 探索细胞衍生的囊泡在瘤治疗中作为药物输送系统的应用.
- 审查这些囊泡的各种药物加载技术.
- 分析不同类型的细胞衍生囊泡的优势和特征,以用于治疗开发.
主要方法:
- 对药物输送中的细胞衍生囊泡研究的文献综述.
- 对基于囊泡的治疗方法的药物加载策略的分析.
- 对不同类型的囊泡及其特性进行比较评估.
主要成果:
- 细胞衍生的囊泡具有显著的潜力,可以生物相容并积极向药物输送系统.
- 与传统载体相比,它们提供了更好的全身循环和有效性.
- 各种药物加载技术正在开发中,以优化它们的治疗有效载荷.
结论:
- 细胞衍生囊泡代表了开发瘤学中先进药物递送系统的有希望的平台.
- 了解它们的特性和优化加载技术对于它们的临床转化至关重要.
- 进一步的研究将有助于充分利用它们的潜力,以有效地治疗瘤.
相关概念视频
01:27Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K